Results 251 to 260 of about 83,455 (287)
Erratum: Are Glucocorticoids Truly Effective in Improving the Clinical Prognosis of HSV-1 Encephalitis? [Corrigendum]. [PDF]
Infect Drug Resisteuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
1998
Almost two centuries ago, long before they were identified as infectious agents, viruses were used for therapeutic applications. In 1798, Jenner discovered that persons inoculated with less pathogenic cowpox (cowpox virus) were protected from subsequent infection with deadly smallpox (variola virus) (1).
Cornel Fraefel +2 more
openaire +1 more source
Almost two centuries ago, long before they were identified as infectious agents, viruses were used for therapeutic applications. In 1798, Jenner discovered that persons inoculated with less pathogenic cowpox (cowpox virus) were protected from subsequent infection with deadly smallpox (variola virus) (1).
Cornel Fraefel +2 more
openaire +1 more source
Immune Control of HSV-1 Latency
Viral Immunology, 2005A hallmark of the herpes family of viruses is their ability to cause recurrent disease. Upon primary infection, Herpes Simplex virus (HSV) establishes a latent infection in sensory neurons that persists for the life of the individual. Reactivation of these latent viral genomes with virion formation is the source of virus for most HSV recurrent disease.
Vilma, Decman +3 more
openaire +2 more sources
SUN2 Modulates the Propagation of HSV-1
Journal of Virology, 2022The large size of herpesviruses prevents them from travelling across the nuclear pores, and they instead egress across the two nuclear membranes, generating short-lived enveloped perinuclear virions. This poses a challenge as the perinuclear space is smaller than the virions.
Kendra Cruz-Palomar +5 more
openaire +2 more sources